Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1998 Oct 6;159(7):807–813.

Prostate cancer: 3. Individual risk factors

R P Gallagher 1, N Fleshner 1
PMCID: PMC1232741  PMID: 9805030

Full Text

The Full Text of this article is available as a PDF (124.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlercreutz H., Markkanen H., Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet. 1993 Nov 13;342(8881):1209–1210. doi: 10.1016/0140-6736(93)92188-y. [DOI] [PubMed] [Google Scholar]
  2. Andersson S. O., Baron J., Wolk A., Lindgren C., Bergström R., Adami H. O. Early life risk factors for prostate cancer: a population-based case-control study in Sweden. Cancer Epidemiol Biomarkers Prev. 1995 Apr-May;4(3):187–192. [PubMed] [Google Scholar]
  3. Armenian H. K., Lilienfeld A. M., Diamond E. L., Bross I. D. Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study. Lancet. 1974 Jul 20;2(7873):115–117. doi: 10.1016/s0140-6736(74)91551-7. [DOI] [PubMed] [Google Scholar]
  4. Armstrong B. G., Kazantzis G. The mortality of cadmium workers. Lancet. 1983 Jun 25;1(8339):1425–1427. doi: 10.1016/s0140-6736(83)92368-1. [DOI] [PubMed] [Google Scholar]
  5. Armstrong B. G., Kazantzis G. The mortality of cadmium workers. Lancet. 1983 Jun 25;1(8339):1425–1427. doi: 10.1016/s0140-6736(83)92368-1. [DOI] [PubMed] [Google Scholar]
  6. Aronson K. J., Siemiatycki J., Dewar R., Gérin M. Occupational risk factors for prostate cancer: results from a case-control study in Montréal, Québec, Canada. Am J Epidemiol. 1996 Feb 15;143(4):363–373. doi: 10.1093/oxfordjournals.aje.a008750. [DOI] [PubMed] [Google Scholar]
  7. Band P. R., Le N. D., Fang R., Deschamps M., Coldman A. J., Gallagher R. P., Moody J. Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol. 1996 Jan 15;143(2):137–143. doi: 10.1093/oxfordjournals.aje.a008722. [DOI] [PubMed] [Google Scholar]
  8. Burmeister L. F., Everett G. D., Van Lier S. F., Isacson P. Selected cancer mortality and farm practices in Iowa. Am J Epidemiol. 1983 Jul;118(1):72–77. doi: 10.1093/oxfordjournals.aje.a113618. [DOI] [PubMed] [Google Scholar]
  9. Cannon-Albright L. A., Thomas A., Goldgar D. E., Gholami K., Rowe K., Jacobsen M., McWhorter W. P., Skolnick M. H. Familiality of cancer in Utah. Cancer Res. 1994 May 1;54(9):2378–2385. [PubMed] [Google Scholar]
  10. Carter B. S., Beaty T. H., Steinberg G. D., Childs B., Walsh P. C. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3367–3371. doi: 10.1073/pnas.89.8.3367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Catalona W. J. Management of cancer of the prostate. N Engl J Med. 1994 Oct 13;331(15):996–1004. doi: 10.1056/NEJM199410133311507. [DOI] [PubMed] [Google Scholar]
  12. Cerhan J. R., Torner J. C., Lynch C. F., Rubenstein L. M., Lemke J. H., Cohen M. B., Lubaroff D. M., Wallace R. B. Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control. 1997 Mar;8(2):229–238. doi: 10.1023/a:1018428531619. [DOI] [PubMed] [Google Scholar]
  13. Clark L. C., Combs G. F., Jr, Turnbull B. W., Slate E. H., Chalker D. K., Chow J., Davis L. S., Glover R. A., Graham G. F., Gross E. G. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996 Dec 25;276(24):1957–1963. [PubMed] [Google Scholar]
  14. Clinton S. K., Emenhiser C., Schwartz S. J., Bostwick D. G., Williams A. W., Moore B. J., Erdman J. W., Jr cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev. 1996 Oct;5(10):823–833. [PubMed] [Google Scholar]
  15. Cooney K. A., McCarthy J. D., Lange E., Huang L., Miesfeldt S., Montie J. E., Oesterling J. E., Sandler H. M., Lange K. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst. 1997 Jul 2;89(13):955–959. doi: 10.1093/jnci/89.13.955. [DOI] [PubMed] [Google Scholar]
  16. Daviglus M. L., Dyer A. R., Persky V., Chavez N., Drum M., Goldberg J., Liu K., Morris D. K., Shekelle R. B., Stamler J. Dietary beta-carotene, vitamin C, and risk of prostate cancer: results from the Western Electric Study. Epidemiology. 1996 Sep;7(5):472–477. [PubMed] [Google Scholar]
  17. Elghany N. A., Schumacher M. C., Slattery M. L., West D. W., Lee J. S. Occupation, cadmium exposure, and prostate cancer. Epidemiology. 1990 Mar;1(2):107–115. doi: 10.1097/00001648-199003000-00005. [DOI] [PubMed] [Google Scholar]
  18. Feldman D. Androgen and vitamin D receptor gene polymorphisms: the long and short of prostate cancer risk. J Natl Cancer Inst. 1997 Jan 15;89(2):109–111. doi: 10.1093/jnci/89.2.109. [DOI] [PubMed] [Google Scholar]
  19. Gallagher R. P., Threlfall W. J., Jeffries E., Band P. R., Spinelli J., Coldman A. J. Cancer and aplastic anemia in British Columbia farmers. J Natl Cancer Inst. 1984 Jun;72(6):1311–1315. [PubMed] [Google Scholar]
  20. Gann P. H., Hennekens C. H., Ma J., Longcope C., Stampfer M. J. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst. 1996 Aug 21;88(16):1118–1126. doi: 10.1093/jnci/88.16.1118. [DOI] [PubMed] [Google Scholar]
  21. Ghadirian P., Howe G. R., Hislop T. G., Maisonneuve P. Family history of prostate cancer: a multi-center case-control study in Canada. Int J Cancer. 1997 Mar 17;70(6):679–681. doi: 10.1002/(sici)1097-0215(19970317)70:6<679::aid-ijc9>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  22. Gilliland F. D., Mandel J. S. Mortality among employees of a perfluorooctanoic acid production plant. J Occup Med. 1993 Sep;35(9):950–954. doi: 10.1097/00043764-199309000-00020. [DOI] [PubMed] [Google Scholar]
  23. Giovannucci E., Ascherio A., Rimm E. B., Stampfer M. J., Colditz G. A., Willett W. C. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst. 1995 Dec 6;87(23):1767–1776. doi: 10.1093/jnci/87.23.1767. [DOI] [PubMed] [Google Scholar]
  24. Giovannucci E., Rimm E. B., Colditz G. A., Stampfer M. J., Ascherio A., Chute C. G., Chute C. C., Willett W. C. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst. 1993 Oct 6;85(19):1571–1579. doi: 10.1093/jnci/85.19.1571. [DOI] [PubMed] [Google Scholar]
  25. Giovannucci E., Rimm E. B., Stampfer M. J., Colditz G. A., Willett W. C. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):557–563. [PubMed] [Google Scholar]
  26. Giovannucci E., Stampfer M. J., Krithivas K., Brown M., Dahl D., Brufsky A., Talcott J., Hennekens C. H., Kantoff P. W. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3320–3323. doi: 10.1073/pnas.94.7.3320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Graham S., Haughey B., Marshall J., Priore R., Byers T., Rzepka T., Mettlin C., Pontes J. E. Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst. 1983 Apr;70(4):687–692. [PubMed] [Google Scholar]
  28. Guess H. A. Is vasectomy a risk factor for prostate cancer? Eur J Cancer. 1993;29A(7):1055–1060. doi: 10.1016/s0959-8049(05)80223-0. [DOI] [PubMed] [Google Scholar]
  29. Haenszel W., Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst. 1968 Jan;40(1):43–68. [PubMed] [Google Scholar]
  30. Hayes R. B., Bogdanovicz J. F., Schroeder F. H., De Bruijn A., Raatgever J. W., Van der Maas P. J., Oishi K., Yoshida O. Serum retinol and prostate cancer. Cancer. 1988 Nov 1;62(9):2021–2026. doi: 10.1002/1097-0142(19881101)62:9<2021::aid-cncr2820620925>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  31. Hayes R. B., Liff J. M., Pottern L. M., Greenberg R. S., Schoenberg J. B., Schwartz A. G., Swanson G. M., Silverman D. T., Brown L. M., Hoover R. N. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer. 1995 Jan 27;60(3):361–364. doi: 10.1002/ijc.2910600315. [DOI] [PubMed] [Google Scholar]
  32. Hirayama T. Epidemiology of prostate cancer with special reference to the role of diet. Natl Cancer Inst Monogr. 1979 Nov;(53):149–155. [PubMed] [Google Scholar]
  33. Honda G. D., Bernstein L., Ross R. K., Greenland S., Gerkins V., Henderson B. E. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer. 1988 Mar;57(3):326–331. doi: 10.1038/bjc.1988.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Hsing A. W., McLaughlin J. K., Schuman L. M., Bjelke E., Gridley G., Wacholder S., Chien H. T., Blot W. J. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res. 1990 Nov 1;50(21):6836–6840. [PubMed] [Google Scholar]
  35. Hunter D. J., Willett W. C. Diet, body size, and breast cancer. Epidemiol Rev. 1993;15(1):110–132. doi: 10.1093/oxfordjournals.epirev.a036096. [DOI] [PubMed] [Google Scholar]
  36. Ingles S. A., Ross R. K., Yu M. C., Irvine R. A., La Pera G., Haile R. W., Coetzee G. A. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst. 1997 Jan 15;89(2):166–170. doi: 10.1093/jnci/89.2.166. [DOI] [PubMed] [Google Scholar]
  37. Kaul L., Heshmat M. Y., Kovi J., Jackson M. A., Jackson A. G., Jones G. W., Edson M., Enterline J. P., Worrell R. G., Perry S. L. The role of diet in prostate cancer. Nutr Cancer. 1987;9(2-3):123–128. doi: 10.1080/01635588709513919. [DOI] [PubMed] [Google Scholar]
  38. Kolonel L. N., Yoshizawa C. N., Hankin J. H. Diet and prostatic cancer: a case-control study in Hawaii. Am J Epidemiol. 1988 May;127(5):999–1012. doi: 10.1093/oxfordjournals.aje.a114903. [DOI] [PubMed] [Google Scholar]
  39. Lesko S. M., Rosenberg L., Shapiro S. Family history and prostate cancer risk. Am J Epidemiol. 1996 Dec 1;144(11):1041–1047. doi: 10.1093/oxfordjournals.aje.a008876. [DOI] [PubMed] [Google Scholar]
  40. McIndoe R. A., Stanford J. L., Gibbs M., Jarvik G. P., Brandzel S., Neal C. L., Li S., Gammack J. T., Gay A. A., Goode E. L. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet. 1997 Aug;61(2):347–353. doi: 10.1086/514853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. McNeal J. E. The zonal anatomy of the prostate. Prostate. 1981;2(1):35–49. doi: 10.1002/pros.2990020105. [DOI] [PubMed] [Google Scholar]
  42. Mettlin C., Selenskas S., Natarajan N., Huben R. Beta-carotene and animal fats and their relationship to prostate cancer risk. A case-control study. Cancer. 1989 Aug 1;64(3):605–612. doi: 10.1002/1097-0142(19890801)64:3<605::aid-cncr2820640307>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  43. Mills P. K., Beeson W. L., Phillips R. L., Fraser G. E. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer. 1989 Aug 1;64(3):598–604. doi: 10.1002/1097-0142(19890801)64:3<598::aid-cncr2820640306>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  44. Monroe K. R., Yu M. C., Kolonel L. N., Coetzee G. A., Wilkens L. R., Ross R. K., Henderson B. E. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med. 1995 Aug;1(8):827–829. doi: 10.1038/nm0895-827. [DOI] [PubMed] [Google Scholar]
  45. Noble R. L. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res. 1977 Jun;37(6):1929–1933. [PubMed] [Google Scholar]
  46. Nomura A. M., Kolonel L. N. Prostate cancer: a current perspective. Epidemiol Rev. 1991;13:200–227. doi: 10.1093/oxfordjournals.epirev.a036069. [DOI] [PubMed] [Google Scholar]
  47. Ohno Y., Yoshida O., Oishi K., Okada K., Yamabe H., Schroeder F. H. Dietary beta-carotene and cancer of the prostate: a case-control study in Kyoto, Japan. Cancer Res. 1988 Mar 1;48(5):1331–1336. [PubMed] [Google Scholar]
  48. Paganini-Hill A., Chao A., Ross R. K., Henderson B. E. Vitamin A, beta-carotene, and the risk of cancer: a prospective study. J Natl Cancer Inst. 1987 Sep;79(3):443–448. [PubMed] [Google Scholar]
  49. Peterson G., Barnes S. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate. 1993;22(4):335–345. doi: 10.1002/pros.2990220408. [DOI] [PubMed] [Google Scholar]
  50. Reichman M. E., Hayes R. B., Ziegler R. G., Schatzkin A., Taylor P. R., Kahle L. L., Fraumeni J. F., Jr Serum vitamin A and subsequent development of prostate cancer in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Cancer Res. 1990 Apr 15;50(8):2311–2315. [PubMed] [Google Scholar]
  51. Rohan T. E., Howe G. R., Burch J. D., Jain M. Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes Control. 1995 Mar;6(2):145–154. doi: 10.1007/BF00052775. [DOI] [PubMed] [Google Scholar]
  52. Ross R. K., Bernstein L., Lobo R. A., Shimizu H., Stanczyk F. Z., Pike M. C., Henderson B. E. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 1992 Apr 11;339(8798):887–889. doi: 10.1016/0140-6736(92)90927-u. [DOI] [PubMed] [Google Scholar]
  53. Ross R. K., Deapen D. M., Casagrande J. T., Paganini-Hill A., Henderson B. E. A cohort study of mortality from cancer of the prostate in Catholic priests. Br J Cancer. 1981 Feb;43(2):233–235. doi: 10.1038/bjc.1981.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Ross R. K., Paganini-Hill A., Henderson B. E. The etiology of prostate cancer: what does the epidemiology suggest? Prostate. 1983;4(4):333–344. doi: 10.1002/pros.2990040403. [DOI] [PubMed] [Google Scholar]
  55. Ross R. K., Shimizu H., Paganini-Hill A., Honda G., Henderson B. E. Case-control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst. 1987 May;78(5):869–874. [PubMed] [Google Scholar]
  56. Ross R., Bernstein L., Judd H., Hanisch R., Pike M., Henderson B. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst. 1986 Jan;76(1):45–48. [PubMed] [Google Scholar]
  57. Rotkin I. D. Studies in the epidemiology of prostatic cancer: expanded sampling. Cancer Treat Rep. 1977 Mar-Apr;61(2):173–180. [PubMed] [Google Scholar]
  58. Severson R. K., Nomura A. M., Grove J. S., Stemmermann G. N. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 1989 Apr 1;49(7):1857–1860. [PubMed] [Google Scholar]
  59. Smith J. R., Freije D., Carpten J. D., Grönberg H., Xu J., Isaacs S. D., Brownstein M. J., Bova G. S., Guo H., Bujnovszky P. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science. 1996 Nov 22;274(5291):1371–1374. doi: 10.1126/science.274.5291.1371. [DOI] [PubMed] [Google Scholar]
  60. Snowdon D. A., Phillips R. L., Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol. 1984 Aug;120(2):244–250. doi: 10.1093/oxfordjournals.aje.a113886. [DOI] [PubMed] [Google Scholar]
  61. Stanford J. L., Just J. J., Gibbs M., Wicklund K. G., Neal C. L., Blumenstein B. A., Ostrander E. A. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res. 1997 Mar 15;57(6):1194–1198. [PubMed] [Google Scholar]
  62. Steinberg G. D., Carter B. S., Beaty T. H., Childs B., Walsh P. C. Family history and the risk of prostate cancer. Prostate. 1990;17(4):337–347. doi: 10.1002/pros.2990170409. [DOI] [PubMed] [Google Scholar]
  63. Talamini R., La Vecchia C., Decarli A., Negri E., Franceschi S. Nutrition, social factors and prostatic cancer in a Northern Italian population. Br J Cancer. 1986 Jun;53(6):817–821. doi: 10.1038/bjc.1986.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Thun M. J., Schnorr T. M., Smith A. B., Halperin W. E., Lemen R. A. Mortality among a cohort of U.S. cadmium production workers--an update. J Natl Cancer Inst. 1985 Feb;74(2):325–333. [PubMed] [Google Scholar]
  65. Thune I., Lund E. Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men. Cancer Causes Control. 1994 Nov;5(6):549–556. doi: 10.1007/BF01831383. [DOI] [PubMed] [Google Scholar]
  66. Vlajinac H. D., Marinković J. M., Ilić M. D., Kocev N. I. Diet and prostate cancer: a case-control study. Eur J Cancer. 1997 Jan;33(1):101–107. doi: 10.1016/s0959-8049(96)00373-5. [DOI] [PubMed] [Google Scholar]
  67. Wang Y., Corr J. G., Thaler H. T., Tao Y., Fair W. R., Heston W. D. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst. 1995 Oct 4;87(19):1456–1462. doi: 10.1093/jnci/87.19.1456. [DOI] [PubMed] [Google Scholar]
  68. West D. W., Slattery M. L., Robison L. M., French T. K., Mahoney A. W. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control. 1991 Mar;2(2):85–94. doi: 10.1007/BF00053126. [DOI] [PubMed] [Google Scholar]
  69. Wheeler G. D., Wall S. R., Belcastro A. N., Cumming D. C. Reduced serum testosterone and prolactin levels in male distance runners. JAMA. 1984 Jul 27;252(4):514–516. [PubMed] [Google Scholar]
  70. Wheeler G. D., Wall S. R., Belcastro A. N., Cumming D. C. Reduced serum testosterone and prolactin levels in male distance runners. JAMA. 1984 Jul 27;252(4):514–516. [PubMed] [Google Scholar]
  71. Whittemore A. S. Colorectal cancer incidence among Chinese in North America and the People's Republic of China: variation with sex, age and anatomical site. Int J Epidemiol. 1989 Sep;18(3):563–568. doi: 10.1093/ije/18.3.563. [DOI] [PubMed] [Google Scholar]
  72. Whittemore A. S., Kolonel L. N., Wu A. H., John E. M., Gallagher R. P., Howe G. R., Burch J. D., Hankin J., Dreon D. M., West D. W. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst. 1995 May 3;87(9):652–661. doi: 10.1093/jnci/87.9.652. [DOI] [PubMed] [Google Scholar]
  73. Whittemore A. S., Wu A. H., Kolonel L. N., John E. M., Gallagher R. P., Howe G. R., West D. W., Teh C. Z., Stamey T. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol. 1995 Apr 15;141(8):732–740. doi: 10.1093/oxfordjournals.aje.a117495. [DOI] [PubMed] [Google Scholar]
  74. Wu A. H., Whittemore A. S., Kolonel L. N., John E. M., Gallagher R. P., West D. W., Hankin J., Teh C. Z., Dreon D. M., Paffenbarger R. S., Jr Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):735–741. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES